Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT00511095
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to give written informed consent
* Women of childbearing potential must be willing to consistently use a highly effective method of birth control
Exclusion Criteria:
* Women who are pregnant or breastfeeding
* Any previous HBV infection
* Previous vaccination (1 or more doses) with any HBV vaccine
* Any previous autoimmune diseases
* Are at high risk for recent exposure to HBV, Hepatitis C Virus (HCV) or Human Immunodeficiency Virus (HIV)
* Received any blood products or antibodies within 3 months prior to study entry
* Ever received an injection with DNA plasmids or oligonucleotides
* Received any vaccines within 4 weeks prior to study entry
* Received any other investigational medicinal agent within 4 weeks prior to study entry
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
11 Years
Maximum Age:
55 Years
Study:
NCT00511095
Study Brief:
Protocol Section:
NCT00511095